EBIT Margin: Earnings before interest and taxes as a portion of total revenues. Calculated as: EBIT / Total Revenues
IDEAYA Biosciences, Inc. (IDYA) had EBIT Margin of 52.18% for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
$207.83M |
|
$119.24M |
|
-- |
|
$207.83M |
|
$99.38M |
|
$108.45M |
|
$10.79M |
|
$119.24M |
|
$119.24M |
|
$119.24M |
|
$119.24M |
|
$119.24M |
|
$119.24M |
|
$108.45M |
|
$107.50M |
|
88.53M |
|
89.69M |
|
$1.35 |
|
$1.33 |
|
| Balance Sheet Financials | |
$802.65M |
|
$8.17M |
|
$382.48M |
|
$1.19B |
|
$64.51M |
|
-- |
|
$28.59M |
|
$93.10M |
|
$1.09B |
|
$1.09B |
|
$1.09B |
|
87.67M |
|
| Cash Flow Statement Financials | |
$19.40M |
|
$167.50M |
|
$27.65M |
|
$85.18M |
|
$299.73M |
|
$214.55M |
|
$34.32M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
12.44 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
52.18% |
|
|
EBIT Margin |
52.18% |
-- |
|
57.37% |
|
57.37% |
|
$17.36M |
|
-- |
|
-- |
|
-- |
|
0.18 |
|
-- |
|
-- |
|
-- |
|
10.92% |
|
10.92% |
|
10.06% |
|
10.92% |
|
$12.46 |
|
$0.19 |
|
$0.22 |
|